Hiroaki Shimizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hiroaki Shimizu has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Masaru Miyazaki
Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
72 shared publications - Atsushi Kato
From the Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba City, Chiba, Japan
58 shared publications Masayuki Ohtsuka
Department of General Surgery, Graduate School of Medicine, Chiba University
57 shared publications- Hideyuki Yoshitomi
Department of Surgery Dokkyo Medical University Saitama Medical Center Koshigaya Japan
48 shared publications - Katsunori Furukawa
Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
42 shared publications - Tsukasa Takayashiki
Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
36 shared publications
Latest Publications
- Open Access
- 1 January 2017
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 78 (4) , 814-819
A Case of Hepatic Metastasis of Meningeal Hemangiopericytoma Diagnosed Preoperatively
症例は43歳,女性.近医で肝腫瘤を指摘され,精査加療目的に当科紹介となった.既往歴として,2年前に髄膜血管周皮腫に対して当院脳神経外科にて開頭腫瘍摘出術を施行されていた.当科受診時の腫瘍マーカーはいずれも陰性であり,肝障害度A,Child-Pugh Aと肝予備能は良好であった.術前の腹部dynamic CT検査では肝S8,S4に早期相で濃染し,遅延相で内部ほぼiso-densityとなる腫瘤を認めた.肝細胞癌との鑑別が問題となったが,既往歴の聴取,および正常肝における多発病変であることから,髄膜血管周皮腫術後・肝転移再発と診断し,肝S8,S4部分切除術を施行した.術後1年10カ月現在,無再発にて外来経過観察中である.慢性肝疾患の既往の無い多血性肝腫瘍に遭遇した際には,詳細な病歴聴取を行い治療方針を検討する必要があると考えられる.
- 1 January 2017
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 78 (4) , 814-819
Open AccessA Case of Hepatic Metastasis of Meningeal Hemangiopericytoma Diagnosed Preoperatively
症例は43歳,女性.近医で肝腫瘤を指摘され,精査加療目的に当科紹介となった.既往歴として,2年前に髄膜血管周皮腫に対して当院脳神経外科にて開頭腫瘍摘出術を施行されていた.当科受診時の腫瘍マーカーはいずれも陰性であり,肝障害度A,Child-Pugh Aと肝予備能は良好であった.術前の腹部dynamic CT検査では肝S8,S4に早期相で濃染し,遅延相で内部ほぼiso-densityとなる腫瘤を認めた.肝細胞癌との鑑別が問題となったが,既往歴の聴取,および正常肝における多発病変であることから,髄膜血管周皮腫術後・肝転移再発と診断し,肝S8,S4部分切除術を施行した.術後1年10カ月現在,無再発にて外来経過観察中である.慢性肝疾患の既往の無い多血性肝腫瘍に遭遇した際には,詳細な病歴聴取を行い治療方針を検討する必要があると考えられる.
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S110
New classification for pancreatic neuroendocrine tumors with sex determining region Y-Box 2 and pancreatic and duodenal homeobox 1
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S110
New classification for pancreatic neuroendocrine tumors with sex determining region Y-Box 2 and pancreatic and duodenal homeobox 1
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S134
Recommended operation methods and its timing for controlling local infection induced by acute necrotizing pancreatitis
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S134
Recommended operation methods and its timing for controlling local infection induced by acute necrotizing pancreatitis
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S175
A case report of undergoing curative resection for initially unresectable pancreatic cancer after chemotherapy and carbon-ion radiotherapy
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S175
A case report of undergoing curative resection for initially unresectable pancreatic cancer after chemotherapy and carbon-ion radiotherapy
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S45
Preoperative chemotherapy using GEM+S-1 for borderline resectable (BR) or unresectable (UR) locally advanced pancreatic cancer
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S45
Preoperative chemotherapy using GEM+S-1 for borderline resectable (BR) or unresectable (UR) locally advanced pancreatic cancer
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S62
Regulation of STAT3 activity by controlling the functions of Pin1 and DRAC effectively inhibits tumor proliferation/invasiveness in human pancreatic ductal adenocarcinoma
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S62
Regulation of STAT3 activity by controlling the functions of Pin1 and DRAC effectively inhibits tumor proliferation/invasiveness in human pancreatic ductal adenocarcinoma
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S115-S116
Annexin II induces gemcitabine resistance via Akt/mTOR signaling pathway and predicts rapid recurrence after surgery in pancreatic cancer
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S115-S116
Annexin II induces gemcitabine resistance via Akt/mTOR signaling pathway and predicts rapid recurrence after surgery in pancreatic cancer
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S59-S60
Surgical outcome of extended pancreatectomy combined with hepatic arterial resection for locally advanced pancreatic cancer
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S59-S60
Surgical outcome of extended pancreatectomy combined with hepatic arterial resection for locally advanced pancreatic cancer
- 1 April 2016
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (4) , 593-600
Low Stromal Area and High Stromal Microvessel Density Predict Poor Prognosis in Pancreatic Cancer
Excessive stroma is a unique property of cancer tissue of the pancreas. The aim of this study was to analyze the relationship of cancer stromal area (SA) and tumor microvessel density (MVD) with prognostic and clinicopathological findings. Pancreatic adenocarcinoma tissues obtained from 104 patients were subjected to cytokeratin 19 and CD31 double immunostaining to identify cancer cells and endothelial cells simultaneously. Stromal area and MVD were assessed in the same sections. Patients were divided into 2 groups for each analysis by the median value of the respective measure. Stromal area negatively correlated with MVD. The low SA group harbored more poorly differentiated carcinoma than the high SA group. Patients of the low SA group showed a higher incidence of hematogenous recurrence. As a consequence, patients in the low SA and the high MVD groups had poorer prognosis in terms of both disease-free survival and overall survival than their respective groups. Multivariate analysis showed that a low SA was an independent prognostic factor for disease-free and overall survival. Our data indicate that the stroma of pancreatic cancer may play an auxiliary role as a barrier to cancer cell invasion. The depletion of tumor stroma alone does not suppress pancreatic cancer progression.
- 1 April 2016
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (4) , 593-600
Low Stromal Area and High Stromal Microvessel Density Predict Poor Prognosis in Pancreatic Cancer
Excessive stroma is a unique property of cancer tissue of the pancreas. The aim of this study was to analyze the relationship of cancer stromal area (SA) and tumor microvessel density (MVD) with prognostic and clinicopathological findings. Pancreatic adenocarcinoma tissues obtained from 104 patients were subjected to cytokeratin 19 and CD31 double immunostaining to identify cancer cells and endothelial cells simultaneously. Stromal area and MVD were assessed in the same sections. Patients were divided into 2 groups for each analysis by the median value of the respective measure. Stromal area negatively correlated with MVD. The low SA group harbored more poorly differentiated carcinoma than the high SA group. Patients of the low SA group showed a higher incidence of hematogenous recurrence. As a consequence, patients in the low SA and the high MVD groups had poorer prognosis in terms of both disease-free survival and overall survival than their respective groups. Multivariate analysis showed that a low SA was an independent prognostic factor for disease-free and overall survival. Our data indicate that the stroma of pancreatic cancer may play an auxiliary role as a barrier to cancer cell invasion. The depletion of tumor stroma alone does not suppress pancreatic cancer progression.
- 1 April 2016
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (4) , 522-527
Expression of Sex Determining Region Y-Box 2 and Pancreatic and Duodenal Homeobox 1 in Pancreatic Neuroendocrine Tumors
Objective The World Health Organization 2010 classification divides pancreatic neuroendocrine tumors (p-NETs) entity to well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocrine carcinomas (NEC) by Ki-67 index. The aim of this study is elucidate the pathophysiology and tumor biology of p-NETs. Methods We assessed the expression of transcription factors sex determining region Y-box 2 (SOX2) and pancreatic and duodenal homeobox 1 (Pdx1)) essential for the normal fetal development of pancreatic neuroendocrine cells in 46 surgically resected p-NETs by immunohistochemistry. The relationship of expression levels of these factors and clinicopathological factors were analyzed. Results SOX2 was positive in 6 p-NETs (13.0%). Five of 7 NEC patients showed positive for SOX2. SOX2 was highly (sensitivity 71%) and specifically (specificity 97%) expressed in NEC. Patients with SOX2 positive p-NET showed the significantly shorter disease-free and overall survival than patients with SOX2 negative p-NET. High Pdx1 expression was seen in 25 p-NET patients (54.3%). None of the NEC patients showed high Pdx1 expression. There was a significant reverse correlation between SOX2 and Pdx1 expression. Conclusions The expression patterns of SOX2 and Pdx1 highly correlated with prognosis of p-NETs. These expression patterns may represent the biological and pathophysiological difference of p-NETs and indicate the origin of tumor.
- 1 April 2016
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (4) , 522-527
Expression of Sex Determining Region Y-Box 2 and Pancreatic and Duodenal Homeobox 1 in Pancreatic Neuroendocrine Tumors
Objective The World Health Organization 2010 classification divides pancreatic neuroendocrine tumors (p-NETs) entity to well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocrine carcinomas (NEC) by Ki-67 index. The aim of this study is elucidate the pathophysiology and tumor biology of p-NETs. Methods We assessed the expression of transcription factors sex determining region Y-box 2 (SOX2) and pancreatic and duodenal homeobox 1 (Pdx1)) essential for the normal fetal development of pancreatic neuroendocrine cells in 46 surgically resected p-NETs by immunohistochemistry. The relationship of expression levels of these factors and clinicopathological factors were analyzed. Results SOX2 was positive in 6 p-NETs (13.0%). Five of 7 NEC patients showed positive for SOX2. SOX2 was highly (sensitivity 71%) and specifically (specificity 97%) expressed in NEC. Patients with SOX2 positive p-NET showed the significantly shorter disease-free and overall survival than patients with SOX2 negative p-NET. High Pdx1 expression was seen in 25 p-NET patients (54.3%). None of the NEC patients showed high Pdx1 expression. There was a significant reverse correlation between SOX2 and Pdx1 expression. Conclusions The expression patterns of SOX2 and Pdx1 highly correlated with prognosis of p-NETs. These expression patterns may represent the biological and pathophysiological difference of p-NETs and indicate the origin of tumor.